Michael Mahoney is Chairman of the Board, President and Chief Executive Officer of Boston Scientific Corp. (BSX). The company reported total compensation of $23,532,050 for fiscal year 2025.
| Salary | $1,442,603 |
|---|---|
| Bonus | $0 |
| Stock awards | $13,608,056 |
| Option awards | $3,749,980 |
| Non-equity incentive plan | $4,002,001 |
| Pension and non-qualified deferred compensation | $441,611 |
| All other compensation | $287,799 |
| Total | $23,532,050 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Boston Scientific Corp. filed March 18, 2026, accession 0000885725-26-000025.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chairman of the Board, President and Chief Executive Officer | $1,442,603 | $0 | $13,608,056 | $3,749,980 | $4,002,001 | $441,611 | $287,799 | $23,532,050 |
| FY2024 | Chairman of the Board President and Chief Executive Officer Chairman of the Board President and Chief Executive Officer Chairman of the Board President and Chief Executive Officer | $1,400,000 | $0 | $12,760,801 | $3,750,000 | $3,255,000 | $0 | $255,000 | $21,420,801 |
| FY2023 | Chairman of the Board President and Chief Executive Officer | $1,400,000 | — | $10,472,753 | $3,124,984 | $3,244,150 | $291,667 | $190,181 | $18,723,735 |
| FY2022 | Chairman of the Board President and Chief Executive Officer | $1,395,178 | — | $9,924,100 | $2,874,985 | $2,278,500 | $376,667 | $92,530 | $16,941,961 |
| FY2021 | Chairman of the Board, President and Chief Executive Officer | $1,344,329 | — | $9,126,292 | $2,749,999 | $2,346,000 | $360,000 | $137,419 | $16,064,039 |
| FY2020 | Chairman of the Board, President and Chief Executive Officer | $666,878 | — | $8,395,367 | $2,749,991 | $1,485,000 | $399,686 | $76,873 | $13,773,795 |
| FY2019 | Chairman of the Board, President and Chief Executive Officer | $1,274,740 | — | $9,087,249 | $2,699,992 | $1,996,800 | $409,290 | $296,069 | $15,764,140 |
Totals as disclosed in each year's own compensation disclosure for Boston Scientific Corp..
| Peer-group chief executive median | $19,780,137 |
|---|---|
| Difference from that median | $3,751,913 |
| Percentile within the disclosed peer group | 71st |
| Peers with a disclosed figure | 14 |
Medians and percentiles are computed across the peer group Boston Scientific Corp. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Michael Mahoney this page | Chairman of the Board, President and Chief Executive Officer | $23,532,050 |
| Joseph Fitzgerald | Executive Vice President and Group President, Cardiovascular | $8,042,997 |
| Arthur Butcher | Executive Vice President and Group President, MedSurg and Asia Pacific | $6,534,719 |
| Daniel Brennan | Former Executive Vice President and Chief Financial Officer | $6,282,896 |
| Jonathan Monson | Executive Vice President and Chief Financial Officer | $6,083,679 |
| Jeffrey Mirviss | Former Executive Vice President and President, Peripheral Interventions | $4,159,959 |
| Vance Brown | Executive Vice President, General Counsel and Corporate Secretary | $3,920,644 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Boston Scientific Corp. compensation brief.
Michael Mahoney's compensation sits inside Boston Scientific Corp.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.